The groundbreaking treatment of the medication represents a major advance in the care of the condition. Unlike existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide143438.blogunteer.com/40676702/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment